← Evidence map

ArticleClinical pharmacokinetics2017

Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment.

Amit Khatri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2016
2017
2018
2019
2020
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27389403